Plain-English translation of NCT06639425 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing Lactobacillus paracasei LC19, a probiotic supplement, to see if it can help people with newly diagnosed type 2 diabetes control their blood sugar levels. About 60 people will take either the medication or a placebo (inactive powder) for 12 weeks. Researchers want to find out if this natural supplement can be a helpful treatment option alongside other diabetes management strategies.
Type 2 diabetes is a condition where the body has trouble managing blood sugar, and many newly diagnosed patients are looking for additional treatment options. This trial explores whether this medication might offer a safe, natural way to help improve blood sugar control in people who have just been diagnosed.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you'll first have blood tests to confirm you're eligible. Then you'll be randomly assigned to take either the probiotic supplement or a placebo powder for 12 weeks. Neither you nor the researchers will know which group you're in (double-blind), which helps ensure fair results. You'll likely have check-in visits during those 12 weeks so researchers can monitor your blood sugar and overall health.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
China